Biosimilaires : Biogen se déleste de Samsung Bioepis
Biogen and Samsung Bioepis present data for Infliximab and Adalimumab biosimilars - Hub Publishing
Samsung BioLogics says report on Biogen deal talks untrue | Fox Business
Samsung in talks to acquire Biogen, per report - The Boston Globe
Is Samsung really 'at negotiating table' for Biogen? What we know so far - MM+M
Samsung in Talks to Buy Alzheimer's Drug Maker Biogen for $42 Billion: Report | Technology News
Logo De Société De Biotechnologie De Biogen Image éditorial - Image du médecines, hématologique: 102563960
Samsung intéressé par le rachat du laboratoire Biogen pour plus de $40 milliards | Arab News FR
Biogen shares jump higher on report of potential Samsung acquisition
Biogen Recoups Much-Needed $2.3B with Sale of Samsung Bioepis Stake | BioSpace
Samsung intéressé par le rachat du laboratoire Biogen | La Presse
Samsung s'associe à Biogen Idec
Samsung Bioepis seeks to buy Biogen biosimilar unit - KED Global
Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn
Biogen of US might reap W2tr from Samsung Bioepis call option
Samsung Biologics buys out Biogen in biosim venture for US$2.3B | HealthCare Middle East & Africa Magazine
Biogen gains ophthalmology biosimilar candidates for Lucentis, Eylea in deal with Samsung Bioepis
Biogen — Wikipédia
Samsung Group reportedly in talks to acquire Biogen < Pharma < Article - KBR
Biogen/Samsung Takeover - Deal Or No Deal?
Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B - Drug Discovery and Development
Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B - Drug Discovery and Development
